Savara Inc (SVRA) Wheel Strategy

Running a SVRA wheel strategy lets you generate consistent premium income on Savara Inc while setting your own entry and exit prices on the underlying. Savara Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own SVRA, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best SVRA wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on SVRA, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable SVRA wheel from a losing one.

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the SVRA wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your SVRA wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.